Solid Ann, I look forward to reading their P3 plans in due course.
Will they go EMA only or come up with a plan that incorporates PMD to try and satisfy what the FDA want to see? In an ideal world clearly they will be able to do so but I'm comfortable that they will do whatever their advice tells them is the best path forwards and if that's EMA only initially then so be it.
The SP action is non-existent and frustrating due to no volume but I'm in this stock for the end game and will continue to be chilled as long as I can see steady progress.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-3
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.885M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 24 | 6.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.7¢ | 7950 | 1 |
View Market Depth
| Last trade - 16.12pm 03/07/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable